EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders

Adam Ioannou, Rishi Patel, Josephine Mansell, Awais Sheikh, Brinda Thillainathan, Yousuf Razvi, Ana Martinez-Naharro, Lucia Venneri, Thirusha Lane, Aviva Petrie, James Moon, Charlotte Manisty und 14 weitere

JACC · 2026

DOI: 10.1016/j.jacc.2026.04.030 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift JACC, 2026. Verfasst von Adam Ioannou und 25 weiteren Autor:innen. Beteiligte Einrichtung: National Amyloidosis Centre, University College London, Royal Free Campus, Rowland Hill Street, London, United Kingdom. Hauptthemen laut MEDLINE: Cardiomyopathies, Arrhythmias, Cardiac, Electrocardiography, Ambulatory, Amyloidosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: AHA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cardiac amyloidosis (CA) is a progressive infiltrative cardiomyopathy associated with conduction disease and arrhythmias, although their true burden and relationship with disease phenotype remain incompletely defined. OBJECTIVES: The purpose of this study was to prospectively characterize arrhythmic burden using implantable loop recorders and explore associations with amyloid subtype and disease characteristics. METHODS: In this prospective single-center observational study, 110 treatment-naïve patients with a new diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) or light-chain cardiac amyloidosis (AL-CA) underwent comprehensive phenotyping, including cardiac magnetic resonance, followed by implantable loop recorder implantation. RESULTS: Among 110 patients (ATTRwt-CM: 43, ATTRv-CM: 20, AL-CA: 47) bradyarrhythmias with a Class I indication for pacemaker implantation occurred in 17.3% and were more frequent in ATTR-CM than AL-CA (15 [23.8%] vs 4 [8.5%]; P = 0.036). Baseline conduction abnormalities (QRS duration: sHR: 1.03; [95% CI: 1.01-1.04]; P < 0.001) and higher myocardial amyloid burden were associated with subsequent bradyarrhythmic events (ECV: sHR: 1.06 [95% CI: 1.02-1.10]; P = 0.002). New atrial fibrillation occurred in 28.2% of patients without prior atrial fibrillation and was more frequent in ATTR-CM than AL-CA (15 [50.0%] vs 5 [12.2%]; P < 0.001) with higher amyloid burden associated with increased risk (ECV: sHR: 1.04; 95% CI: 1.00-1.08; P = 0.038). During follow-up 21 (19.1%) patients died (ATTR-CM: 10 [15.9%]; AL-CA: 11[23.4%]). In patients with ATTR-CM, the terminal cardiac rhythm was uniformly pulseless electrical activity; in patients with AL-CA, PEA was the terminal rhythm in 9 (81.8%) patients and 2 (18.2%) had sustained ventricular arrhythmias. CONCLUSIONS: In CA, clinically significant arrhythmias are common and frequently asymptomatic. Arrhythmic burden and patterns differ between amyloid subtypes and are closely associated with disease phenotype and myocardial amyloid burden. These findings provide prospective insights into arrhythmogenesis in CA and support the need for further studies to refine risk stratification and inform management strategies. (Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders [EXCALIBUR]; NCT04856267).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomyopathiesArrhythmias, CardiacElectrocardiography, AmbulatoryAmyloidosisHumansFemaleMaleProspective StudiesAgedMiddle AgedAmyloid Neuropathies, Familial

Stichwörter der Autor:innen

arrhythmiacardiac amyloidosiscardiac light-chain amyloidosistransthyretin amyloid cardiomyopathy

Autor:innen und Institutionen

  • National Amyloidosis Centre, University College London, Royal Free Campus, Rowland Hill Street, London, United Kingdom.
  • University College London, London, United Kingdom.
  • Barts Heart Centre, London, United Kingdom.
  • Royal Free Hospital, Pond Street, London, United Kingdom.
  • National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • National Heart Blood and Lung Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA.

Förderung

  • AHA

Zitieren

APA

Ioannou, A., Patel, R., Mansell, J., Sheikh, A., Thillainathan, B., Razvi, Y., Martinez-Naharro, A., Venneri, L., Lane, T., Petrie, A., Moon, J., Manisty, C., Lachmann, H., Hawkins, P. N., Galpert, J., Keene, D., Kellman, P., Solomon, S. D., Knight, D. S., …, & Fontana, M. (2026). Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders. JACC. https://doi.org/10.1016/j.jacc.2026.04.030

Vancouver

Ioannou A, Patel R, Mansell J, Sheikh A, Thillainathan B, Razvi Y, et al. Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders. JACC. 2026. doi:10.1016/j.jacc.2026.04.030

BibTeX
@article{Ioannou2026,
  author = {Ioannou, Adam and Patel, Rishi and Mansell, Josephine and Sheikh, Awais and Thillainathan, Brinda and Razvi, Yousuf and Martinez-Naharro, Ana and Venneri, Lucia and Lane, Thirusha and Petrie, Aviva and Moon, James and Manisty, Charlotte and Lachmann, Helen and Hawkins, Philip N and Galpert, Jacob and Keene, Daniel and Kellman, Peter and Solomon, Scott D and Knight, Daniel S and Kotecha, Tushar and Lockie, Tim and Patel, Niket and Khiani, Raj and Wechalekar, Ashutosh and Gillmore, Julian D and Fontana, Marianna},
  title = {Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders},
  journal = {JACC},
  year = {2026},
  doi = {10.1016/j.jacc.2026.04.030}
}
Kostenlos starten →